Massive study checks arthritis drug for cancer risk
NCT ID NCT05421442
Summary
This study aimed to monitor the long-term safety of the arthritis drug abatacept after it was approved for use. It tracked over 38,000 people in Denmark with rheumatoid or psoriatic arthritis who were taking the drug. The main goal was to see how often certain cancers, especially skin cancers, occurred in these patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Lawrenceville, New Jersey, 08543, United States
Conditions
Explore the condition pages connected to this study.